S. Ozono
Impact in
- Urology top 5%
- Urinary Bladder and Prostate Research
-
- Renal cell carcinoma treatment
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
-
- Renal cell carcinoma treatment 14
- Prostate Cancer Treatment and Research 11
- Surgery 19
- Bladder and Urothelial Cancer Treatments 11
- Urinary and Genital Oncology Studies 5
- Co-authors
- Yoshihiko Hirao (26 shared papers)Hideyuki Akaza (10 shared papers)Hirotsugu Uemura (5 shared papers)Akira Yokomizo (2 shared papers)E Okajima (13 shared papers)Tadashi Tsukamoto (5 shared papers)Takeshi Ueda (2 shared papers)Yasutomo Nasu (1 shared paper)
- Journals
- Japanese Journal of Clinical Oncology (15 papers)European Urology (2 papers)Journal of Clinical Oncology (2 papers)The Journal of Urology (2 papers)Acta Oncologica (1 paper)
- Partner nations
- JapanUnited StatesBelgium
In The Last Decade
S. Ozono
61 papers receiving 585 citations
Peers
Comparison fields: 5 of 78
- Urology 58
- Pulmonary and Respiratory Medicine 263
- Transplantation 19
- Cancer Research 53
- Oncology 66
Countries citing papers authored by S. Ozono
This map shows the geographic impact of S. Ozono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Ozono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Ozono more than expected).
Fields of papers citing papers by S. Ozono
This network shows the impact of papers produced by S. Ozono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Ozono. The network helps show where S. Ozono may publish in the future.
Co-authors
The 25 scholars most cited alongside S. Ozono, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 67 | |
| 2 | 2010 | 62 | |
| 3 | 2004 | 61 | |
| 4 | 2000 | 40 | |
| 5 | 2014 | 29 | |
| 6 | 2012 | 28 | |
| 7 | 2014 | 24 | |
| 8 | 1991 | 23 | |
| 9 | 2010 | 21 | |
| 10 | 1988 | 17 | |
| 11 | 2002 | 17 | |
| 12 | 2001 | 16 | |
| 13 | 2011 | 14 | |
| 14 | 2013 | 13 | |
| 15 | 2001 | 13 | |
| 16 | 2006 | 13 | |
| 17 | 1988 | 12 | |
| 18 | 1993 | 12 | |
| 19 | 2005 | 11 | |
| 20 | 1987 | 10 |
About S. Ozono
S. Ozono is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Molecular Biology, Pediatrics, Perinatology and Child Health and Urology, having authored 64 papers that have together received 609 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (14 papers), Bladder and Urothelial Cancer Treatments (11 papers), Prostate Cancer Treatment and Research (11 papers), Renal and related cancers (6 papers), Urinary and Genital Oncology Studies (5 papers), Polyamine Metabolism and Applications (4 papers), Amino Acid Enzymes and Metabolism (4 papers) and Urologic and reproductive health conditions (3 papers). The work is most often cited by research in Urology (58 citations), Pulmonary and Respiratory Medicine (263 citations), Transplantation (19 citations), Cancer Research (53 citations) and Oncology (66 citations). S. Ozono has collaborated with scholars based in Japan, United States and Belgium. Frequent co-authors include Yoshihiko Hirao, Hideyuki Akaza, Hirotsugu Uemura, Akira Yokomizo, E Okajima, Tadashi Tsukamoto, Takeshi Ueda, Yasutomo Nasu, Naoto Miyanaga and Naoya Masumori. Their work appears in journals such as Japanese Journal of Clinical Oncology, European Urology, Journal of Clinical Oncology, The Journal of Urology and Acta Oncologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.